{"id":5603,"date":"2015-01-07T13:19:47","date_gmt":"2015-01-07T18:19:47","guid":{"rendered":"http:\/\/www.bumc.bu.edu\/busm\/?p=5603"},"modified":"2015-01-07T13:19:47","modified_gmt":"2015-01-07T18:19:47","slug":"many-insurers-dont-cover-drugs-for-weight-loss","status":"publish","type":"post","link":"https:\/\/www.bumc.bu.edu\/camed\/2015\/01\/07\/many-insurers-dont-cover-drugs-for-weight-loss\/","title":{"rendered":"Many Insurers Don&#8217;t Cover Drugs For Weight Loss"},"content":{"rendered":"<h3><a href=\"https:\/\/www.bumc.bu.edu\/camed\/2015\/01\/09\/many-insurers-dont-cover-drugs-for-weight-loss\/caroline-apovian-300x300-150x150\/\" rel=\"attachment wp-att-5614\"><img loading=\"lazy\" src=\"\/camed\/files\/2015\/01\/Caroline-Apovian-300x300-150x150.jpg\" alt=\"Caroline-Apovian-300x300-150x150\" width=\"150\" height=\"150\" class=\"alignleft size-full wp-image-5614\" \/><\/a>NPR &#8220;Shots Blog&#8221;<\/h3>\n<h4><a href=\"http:\/\/www.bu.edu\/experts\/profiles\/caroline-apovian\/\">Caroline Apovian<\/a>, MD, medicine and pediatrics<\/h4>\n<p>In\u00a0December, the Food and Drug Administration approved a new obesity drug, Saxenda, the fourth prescription medicine the agency has given the green light to fight obesity since 2012. But even though two-thirds of adults are overweight or obese, there&#8217;s a good chance their insurer won&#8217;t cover Saxenda or other anti-obesity drugs&#8230;<\/p>\n<h3>Expert quote:<\/h3>\n<p>Dr. Caroline Apovian, director of the Nutrition and Weight Management Research Center at Boston University, says many of the patients she treats can&#8217;t afford to pay up to $200 a month out of pocket for obesity drugs.<\/p>\n<p>&#8220;Coverage has to happen in order for the obesity problem to be taken care of,&#8221; says Apovian. &#8220;Insurance companies need to realize it&#8217;s not a matter of willpower, it&#8217;s a disease.&#8221;<\/p>\n<p>Read the <a href=\"http:\/\/www.npr.org\/blogs\/health\/2015\/01\/06\/375198217\/many-insurers-dont-cover-drugs-for-weight-loss\">full article<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>NPR &#8220;Shots Blog&#8221; Caroline Apovian, MD, medicine and pediatrics In\u00a0December, the Food and Drug Administration approved a new obesity drug, Saxenda, the fourth prescription medicine the agency has given the green light to fight obesity since 2012. But even though two-thirds of adults are overweight or obese, there&#8217;s a good chance their insurer won&#8217;t cover [&hellip;]<\/p>\n","protected":false},"author":7398,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[126],"tags":[125],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/posts\/5603"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/users\/7398"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/comments?post=5603"}],"version-history":[{"count":0,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/posts\/5603\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/media?parent=5603"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/categories?post=5603"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/tags?post=5603"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}